Related Experiment Video

Updated: May 23, 2026

Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome
09:06

Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome

Published on: December 12, 2025

Mesenchymal stem cell therapy in acute lung injury: is it time for a clinical trial?

Rob Mac Sweeney, Daniel Francis McAuley

    Thorax
    |April 17, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
    08:24

    Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

    Published on: May 25, 2020

    Related Experiment Videos

    Last Updated: May 23, 2026

    Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome
    09:06

    Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome

    Published on: December 12, 2025

    Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
    08:24

    Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

    Published on: May 25, 2020

    Related Concept Videos

    Mesenchymal Stem Cells01:19

    Mesenchymal Stem Cells

    Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

    Articles linked to this work by shared authors, journal, and citation graph.

    Effects of hyperoxia on pulmonary inflammation and organ injury in a human in vivo model (HIPI): a randomised controlled trial.

    Thorax·2026

    SHORTER trial: protocol for a pragmatic, multicentre, randomised controlled trial of short-duration antibiotic therapy for critically ill patients with sepsis.

    BMJ open·2026

    Greater recovery after critical illness (GRACE): a call to action to create a new roadmap for critical illness research.

    Thorax·2025

    Safety and effectiveness of statins in hospitalized patients with COVID-19: Systematic review and collaborative meta-analysis of randomized controlled trials.

    Thrombosis research·2025

    Effect of simvastatin on postoperative complications in patients undergoing one-lung ventilation during surgery: the Prevention HARP-2 randomised controlled trial.

    Thorax·2025

    Effects of Hyperoxia on Pulmonary Inflammation and organ injury in a human in vivo model (HIPI): study protocol of a randomised, double-blind, placebo-controlled trial.

    BMJ open respiratory research·2025

    Randomised controlled trial of partitioned aerobic exercise training using one-leg cycling in patients with idiopathic pulmonary fibrosis.

    Thorax·2026

    Prevalence of asthma among African children and adolescents: findings from the Chronic Respiratory Disease Observatory for Africa (CHEST-Africa).

    Thorax·2026

    Phase 1b ATMOS trial of the inhaled sGC activator mosliciguat in patients with PAH/CTEPH.

    Thorax·2026

    Markers of microvascular instability predict severity and survival in idiopathic pulmonary fibrosis.

    Thorax·2026

    Familial pulmonary fibrosis: a UK consensus framework for the investigation and management of patients and their relatives.

    Thorax·2026

    [Mesenchymal Stem Cells as Anti-Tumor Therapeutics-Current Status and Challenges].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026

    A hospital-based HTA model to assess the economic and organizational impact of intravenous-to-subcutaneous monoclonal antibody transitions in oncology.

    International journal of technology assessment in health care·2026

    Kit-based remote collection and isolation of human reprogrammable somatic cells for generation of induced pluripotent stem cells and cerebral organoids.

    Nature protocols·2026

    Clinical safety and preliminary efficacy of allogeneic human induced pluripotent stem cell-derived exosomes in patients with acute ischaemic stroke: protocol of a phase I/II clinical trial in China.

    BMJ open·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us